Weak reporting systems, limited resources, and cultural barriers continue to hinder drug safety monitoring in developing countries. This article explores the core challenges affecting adverse drug reaction reporting and outlines the key drivers—technology, global collaboration, and expanding healthcare access—that can transform pharmacovigilance systems for safer, more equitable healthcare.
Download the whitepaper to read more →
